A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To document the efficacy of Imiquimod 5% cream in the treatment of hemangioma of infancy.
Cream is applied for 4 months. Visits occured at month 1, 2, 4, and 8.
Catherine McCuaig, M.D.
St. Justine's Hospital
Canada: Health Canada